H
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Price:
1.58
CNY
Market Closed
Market Cap:
¥7.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
CN |
|
Karma Energy Ltd
NSE:KARMAENG
|
IN |
|
H
|
Hyungji Elite Inc
KRX:093240
|
KR |
|
City Cement Company CJSC
SAU:3003
|
SA |
|
W
|
Wesizwe Platinum Ltd
JSE:WEZ
|
ZA |
|
Soechi Lines Tbk PT
IDX:SOCI
|
ID |
|
Grupo Famsa SAB de CV
BMV:GFAMSAA
|
MX |
|
Accelerant Holdings
NYSE:ARX
|
KY |
|
Bluestone Resources Inc
XTSX:BSR
|
CA |
|
Bankwell Financial Group Inc
NASDAQ:BWFG
|
US |
|
H
|
HansaeMK Co Ltd
KRX:069640
|
KR |
|
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
|
CN |
|
Rocketfuel Blockchain Inc
OTC:RKFL
|
US |
|
Hiliks Technologies Ltd
BSE:539697
|
IN |
|
Invinity Energy Systems PLC
OTC:IESVF
|
JE |
|
N
|
Naturgy BAN SA
BCBA:GBAN
|
AR |
|
M
|
Million Hope Industries Holdings Ltd
HKEX:1897
|
HK |
|
S
|
SoCar Inc
KRX:403550
|
KR |
|
Bluesky Digital Assets Corp
OTC:BTCWF
|
CA |
|
Microsaic Systems PLC
LSE:MSYS
|
UK |
|
M
|
Mitrajaya Holdings Bhd
KLSE:MHB
|
MY |
|
N
|
Nestle SA
BMV:NESNN
|
CH |
Wall Street
Price Targets
Price Targets Summary
Hubei Biocause Pharmaceutical Co Ltd
Hubei Biocause Pharmaceutical Co Ltd
There are no price targets for Hubei Biocause Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hubei Biocause Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hubei Biocause Pharmaceutical Co Ltd's stock price target?
Not Available
Hubei Biocause Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hubei Biocause Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-43%
-43%
For the last 13 years the compound annual growth rate for Hubei Biocause Pharmaceutical Co Ltd's revenue is 33%. The projected CAGR for the next 8 years is -43%.
